HK1072957A1 - In vitro peptide expression libraray - Google Patents
In vitro peptide expression librarayInfo
- Publication number
- HK1072957A1 HK1072957A1 HK05104771.2A HK05104771A HK1072957A1 HK 1072957 A1 HK1072957 A1 HK 1072957A1 HK 05104771 A HK05104771 A HK 05104771A HK 1072957 A1 HK1072957 A1 HK 1072957A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- libraray
- peptide expression
- vitro peptide
- library
- making
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
- C12N15/1034—Isolating an individual clone by screening libraries
- C12N15/1075—Isolating an individual clone by screening libraries by coupling phenotype to genotype, not provided for in other groups of this subclass
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/80—Fusion polypeptide containing a DNA binding domain, e.g. Lacl or Tet-repressor
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Genetics & Genomics (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Plant Pathology (AREA)
- Biophysics (AREA)
- Microbiology (AREA)
- Physics & Mathematics (AREA)
- Crystallography & Structural Chemistry (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Computational Biology (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB0220759A GB0220759D0 (en) | 2002-09-06 | 2002-09-06 | Display library |
GB0304521A GB0304521D0 (en) | 2003-02-27 | 2003-02-27 | Display library |
GB0304657A GB0304657D0 (en) | 2003-02-28 | 2003-02-28 | Display library |
PCT/GB2003/003860 WO2004022746A1 (en) | 2002-09-06 | 2003-09-05 | In vitro peptide expression libraray |
Publications (1)
Publication Number | Publication Date |
---|---|
HK1072957A1 true HK1072957A1 (en) | 2005-09-16 |
Family
ID=31982028
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK05104771.2A HK1072957A1 (en) | 2002-09-06 | 2005-06-07 | In vitro peptide expression libraray |
Country Status (15)
Country | Link |
---|---|
US (2) | US7842476B2 (xx) |
EP (2) | EP1534830B1 (xx) |
JP (1) | JP4664677B2 (xx) |
KR (1) | KR101051245B1 (xx) |
CN (1) | CN100351375C (xx) |
AT (1) | ATE488586T1 (xx) |
AU (1) | AU2003260786B2 (xx) |
CA (1) | CA2497496C (xx) |
DE (1) | DE60335000D1 (xx) |
DK (1) | DK1534830T3 (xx) |
HK (1) | HK1072957A1 (xx) |
IL (1) | IL166903A (xx) |
NO (1) | NO332949B1 (xx) |
PT (1) | PT1534830E (xx) |
WO (1) | WO2004022746A1 (xx) |
Families Citing this family (60)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB0418651D0 (en) * | 2004-08-20 | 2004-09-22 | Medical Res Council | Method |
GB0505420D0 (en) * | 2005-03-16 | 2005-04-20 | Isogenica Ltd | Stable ligand selection method |
GB0515115D0 (en) | 2005-07-22 | 2005-08-31 | Isogenica Ltd | Peptide characterisation |
GB0806562D0 (en) * | 2008-04-10 | 2008-05-14 | Fermentas Uab | Production of nucleic acid |
EP3629022A1 (en) | 2008-07-25 | 2020-04-01 | Richard W. Wagner | Protein screening methods |
RS55218B1 (sr) | 2008-10-31 | 2017-02-28 | Janssen Biotech Inc | Kompozicije fibronektin tip iii skalno baziranih domena, metode i upotrebe |
WO2010099477A2 (en) | 2009-02-27 | 2010-09-02 | Atyr Pharma, Inc. | Polypeptide structural motifs associated with cell signaling activity |
GB201000352D0 (en) | 2010-01-11 | 2010-02-24 | Isogenica Ltd | Antimicrobial peptides |
US8980253B2 (en) | 2010-04-26 | 2015-03-17 | Atyr Pharma, Inc. | Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of cysteinyl-tRNA synthetase |
CN103096911B (zh) | 2010-04-27 | 2018-05-29 | Atyr 医药公司 | 与异亮氨酰-tRNA合成酶的蛋白片段相关的治疗、诊断和抗体组合物的创新发现 |
US8986681B2 (en) | 2010-04-27 | 2015-03-24 | Atyr Pharma, Inc. | Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of threonyl-tRNA synthetases |
AU2011248489B2 (en) | 2010-04-28 | 2016-10-06 | Pangu Biopharma Limited | Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of alanyl tRNA synthetases |
CN103097523B (zh) | 2010-04-29 | 2016-09-28 | Atyr医药公司 | 与天冬酰胺酰-tRNA合成酶的蛋白片段相关的治疗、诊断和抗体组合物的创新发现 |
WO2011150279A2 (en) | 2010-05-27 | 2011-12-01 | Atyr Pharma, Inc. | Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of glutaminyl-trna synthetases |
EP2563383B1 (en) | 2010-04-29 | 2017-03-01 | Atyr Pharma, Inc. | Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of valyl trna synthetases |
AU2011245225B2 (en) | 2010-04-30 | 2015-09-17 | Janssen Biotech, Inc. | Stabilized fibronectin domain compositions, methods and uses |
EP2566496B1 (en) | 2010-05-03 | 2018-02-28 | aTyr Pharma, Inc. | Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of methionyl-trna synthetases |
CN103108655B (zh) | 2010-05-03 | 2017-04-05 | Atyr 医药公司 | 与丝氨酰‑tRNA合成酶的蛋白片段相关的治疗、诊断和抗体组合物的创新发现 |
US9034321B2 (en) | 2010-05-03 | 2015-05-19 | Atyr Pharma, Inc. | Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of phenylalanyl-alpha-tRNA synthetases |
CA2797277C (en) | 2010-05-03 | 2021-02-23 | Atyr Pharma, Inc. | Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of arginyl-trna synthetases |
CA2798139C (en) | 2010-05-04 | 2019-09-24 | Atyr Pharma, Inc. | Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of p38 multi-trna synthetase complex |
CA2798301C (en) | 2010-05-04 | 2020-09-15 | Atyr Pharma, Inc. | Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of glutamyl-prolyl-trna synthetases |
CN103200953B (zh) | 2010-05-14 | 2017-02-15 | Atyr 医药公司 | 与苯丙氨酰‑β‑tRNA合成酶的蛋白片段相关的治疗、诊断和抗体组合物的创新发现 |
CN103096914B (zh) | 2010-05-17 | 2015-08-12 | Atyr医药公司 | 与亮氨酰-tRNA合成酶的蛋白片段相关的治疗、诊断和抗体组合物的创新发现 |
AU2011261486B2 (en) | 2010-06-01 | 2017-02-23 | Pangu Biopharma Limited | Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of lysyl-tRNA synthetases |
US8999321B2 (en) | 2010-07-12 | 2015-04-07 | Atyr Pharma, Inc. | Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of glycyl-tRNA synthetases |
KR20130102534A (ko) | 2010-07-12 | 2013-09-17 | 에이티와이알 파마, 인코포레이티드 | 히스티딜trna 합성효소의 단백질 단편에 관련된 치료적, 진단적, 및 항체 조성물의 혁신적 발견 |
NZ603811A (en) | 2010-07-12 | 2015-03-27 | Atyr Pharma Inc | Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of aspartyl-trna synthetases |
EP2593125B1 (en) | 2010-07-12 | 2017-11-01 | aTyr Pharma, Inc. | Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of glycyl-trna synthetases |
GB201013284D0 (en) | 2010-08-06 | 2010-09-22 | Isogenica Ltd | Scaffold peptides |
CN103108650A (zh) | 2010-08-25 | 2013-05-15 | Atyr医药公司 | 与酪氨酰-tRNA合成酶的蛋白片段相关的治疗、诊断和抗体组合物的创新发现 |
CA2812795C (en) | 2010-10-06 | 2021-08-31 | Atyr Pharma, Inc. | Innovative discovery of therapeutic, diagnostic, and antibody compositions related protein fragments of tryptophanyl trna synthetases |
JP5920835B2 (ja) | 2010-12-01 | 2016-05-18 | 田辺三菱製薬株式会社 | 無細胞翻訳系でFabを提示しうるポリヌクレオチド構築物ならびにそれを用いたFabの製造方法およびスクリーニング方法 |
US9714419B2 (en) | 2011-08-09 | 2017-07-25 | Atyr Pharma, Inc. | PEGylated tyrosyl-tRNA synthetase polypeptides |
EP4151785A1 (en) | 2011-09-27 | 2023-03-22 | Janssen Biotech, Inc. | Fibronectin type iii repeat based protein scaffolds with alternative binding surfaces |
US20130090247A1 (en) | 2011-10-11 | 2013-04-11 | Biolauncher Ltd. | Methods and systems for identification of binding pharmacophores |
US20130090265A1 (en) | 2011-10-11 | 2013-04-11 | Biolauncher Ltd. | Systems and methods for generation of context-specific, molecular field-based amino acid substitution matrices |
US20130090266A1 (en) | 2011-10-11 | 2013-04-11 | Biolauncher Ltd. | Methods and systems for optimization of peptide screening |
US9816084B2 (en) | 2011-12-06 | 2017-11-14 | Atyr Pharma, Inc. | Aspartyl-tRNA synthetases |
US9822353B2 (en) | 2011-12-06 | 2017-11-21 | Atyr Pharma, Inc. | PEGylated aspartyl-tRNA synthetase polypeptides |
CA2858613A1 (en) | 2011-12-29 | 2013-08-08 | Atyr Pharma, Inc. | Aspartyl-trna synthetase-fc conjugates |
GB2500243A (en) * | 2012-03-15 | 2013-09-18 | Isogenica Ltd | Identifying members of immobilised peptide libraries comprising protein-DNA complexes |
US9695228B2 (en) | 2012-11-21 | 2017-07-04 | Janssen Biotech, Inc. | EGFR and c-Met fibronectin type III domain binding molecules |
LT3447069T (lt) | 2012-11-21 | 2020-12-10 | Janssen Biotech, Inc. | Bispecifiniai egfr/c-met antikūnai |
AU2014233436B2 (en) | 2013-03-15 | 2019-12-05 | Atyr Pharma, Inc. | Histidyl-tRNA synthetase-Fc conjugates |
KR102478402B1 (ko) | 2013-10-14 | 2022-12-15 | 얀센 바이오테크 인코포레이티드 | 시스테인 조작된 피브로넥틴 iii형 도메인 결합 분자 |
WO2016134521A1 (en) | 2015-02-27 | 2016-09-01 | The University Of Hong Kong | Dna display and methods thereof |
CN107708720A (zh) | 2015-04-06 | 2018-02-16 | 苏伯多曼有限责任公司 | 含有从头结合结构域的多肽及其用途 |
BR112017023798A2 (pt) | 2015-05-06 | 2018-10-16 | Janssen Biotech Inc | domínios fibronectina tipo iii de ligação a antígeno prostático específico de membrana |
CN109562146A (zh) * | 2016-06-03 | 2019-04-02 | 詹森生物科技公司 | 血清白蛋白结合纤连蛋白iii型结构域 |
US10662235B2 (en) | 2016-06-21 | 2020-05-26 | Janssen Biotech, Inc. | Cysteine engineered fibronectin type III domain binding molecules |
MA46236A (fr) | 2016-09-14 | 2019-07-24 | Janssen Biotech Inc | Récepteurs antigéniques chimériques comprenant des domaines de la fibronectine de type iii spécifiques du bcma, et utilisations correspondantes |
EP3554561B1 (en) | 2016-12-14 | 2023-06-28 | Janssen Biotech, Inc. | Cd137 binding fibronectin type iii domains |
JP7104703B2 (ja) | 2016-12-14 | 2022-07-21 | ヤンセン バイオテツク,インコーポレーテツド | Cd8a結合フィブロネクチンiii型ドメイン |
WO2018111976A1 (en) | 2016-12-14 | 2018-06-21 | Janssen Biotech, Inc. | Pd-l1 binding fibronectin type iii domains |
EP3600394A4 (en) | 2017-03-22 | 2021-04-14 | Research Corporation Technologies, Inc. | MANIPULATED STABLE CH2-POLYPEPTIDES |
JP2020517638A (ja) | 2017-04-20 | 2020-06-18 | エータイアー ファーマ, インコーポレイテッド | 肺の炎症を治療するための組成物および方法 |
US11078263B2 (en) | 2017-08-25 | 2021-08-03 | Janssen Biotech, Inc. | Fc γ RIII binding fibronectin type III domains, their conjugates and multispecific molecules comprising them |
JP2022551204A (ja) | 2019-10-14 | 2022-12-07 | アロ・バイオセラピューティクス・カンパニー | Cd71結合フィブロネクチンiii型ドメイン |
US11781138B2 (en) | 2019-10-14 | 2023-10-10 | Aro Biotherapeutics Company | FN3 domain-siRNA conjugates and uses thereof |
Family Cites Families (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP3127158B2 (ja) | 1989-10-05 | 2001-01-22 | オプテイン,インコーポレイティド | 新規の遺伝子及びポリペチドの無細胞合成並びに単離 |
EP0593618B1 (en) * | 1991-06-27 | 1998-04-22 | Genelabs Technologies, Inc. | Screening assay for the detection of dna-binding molecules |
US5733731A (en) | 1991-10-16 | 1998-03-31 | Affymax Technologies N.V. | Peptide library and screening method |
GB9703369D0 (en) | 1997-02-18 | 1997-04-09 | Lindqvist Bjorn H | Process |
ES2209145T5 (es) * | 1997-05-28 | 2009-10-30 | Crescendo Biologics Ltd. | Complejos de ribosomas como particulas de seleccion para el desarrollo in vitro y evolucion de proteinas. |
DE69838521T2 (de) | 1997-07-07 | 2008-05-21 | Medical Research Council | Methode zur Erhöhung der Konzentration von Nucleinsäuremolekülen |
GB9718455D0 (en) * | 1997-09-02 | 1997-11-05 | Mcgregor Duncan P | Chimeric binding peptide library screening method |
GB9900298D0 (en) | 1999-01-07 | 1999-02-24 | Medical Res Council | Optical sorting method |
AU4499499A (en) | 1999-04-01 | 2000-10-23 | Innogenetics N.V. | A polypeptide structure for use as a scaffold |
JP3750020B2 (ja) | 2000-12-07 | 2006-03-01 | 学校法人慶應義塾 | C末端修飾タンパク質およびその製造方法、ならびに、c末端修飾タンパク質の製造に用いる修飾剤および翻訳テンプレート、ならびに、c末端修飾タンパク質を用いたタンパク質相互作用の検出方法 |
JP4963142B2 (ja) | 2000-12-14 | 2012-06-27 | 学校法人慶應義塾 | 遺伝子型と表現型の対応付け分子とその構成要素、および対応付け分子の製造方法と利用方法 |
JP3706942B2 (ja) | 2001-08-07 | 2005-10-19 | 学校法人慶應義塾 | 物質と蛋白質との間の相互作用の検出方法、物質と相互作用する蛋白質のスクリーニング方法、及び、物質とその物質と相互作用する蛋白質との複合体の形成方法 |
US20060156511A1 (en) * | 2005-01-19 | 2006-07-20 | Li Yuan J | Caster |
-
2003
- 2003-09-05 JP JP2004533653A patent/JP4664677B2/ja not_active Expired - Fee Related
- 2003-09-05 CA CA2497496A patent/CA2497496C/en not_active Expired - Fee Related
- 2003-09-05 EP EP03793896A patent/EP1534830B1/en not_active Expired - Lifetime
- 2003-09-05 PT PT03793896T patent/PT1534830E/pt unknown
- 2003-09-05 DE DE60335000T patent/DE60335000D1/de not_active Expired - Lifetime
- 2003-09-05 AT AT03793896T patent/ATE488586T1/de active
- 2003-09-05 DK DK03793896.6T patent/DK1534830T3/da active
- 2003-09-05 WO PCT/GB2003/003860 patent/WO2004022746A1/en active Application Filing
- 2003-09-05 US US10/526,479 patent/US7842476B2/en active Active
- 2003-09-05 KR KR1020057003832A patent/KR101051245B1/ko active IP Right Grant
- 2003-09-05 CN CNB038211343A patent/CN100351375C/zh not_active Expired - Lifetime
- 2003-09-05 AU AU2003260786A patent/AU2003260786B2/en not_active Ceased
- 2003-09-05 EP EP10010747A patent/EP2385118A1/en not_active Withdrawn
-
2005
- 2005-02-15 IL IL166903A patent/IL166903A/en active IP Right Grant
- 2005-04-05 NO NO20051685A patent/NO332949B1/no not_active IP Right Cessation
- 2005-06-07 HK HK05104771.2A patent/HK1072957A1/xx not_active IP Right Cessation
-
2010
- 2010-10-21 US US12/909,420 patent/US8679781B2/en active Active
Also Published As
Publication number | Publication date |
---|---|
EP1534830B1 (en) | 2010-11-17 |
AU2003260786B2 (en) | 2008-03-13 |
NO332949B1 (no) | 2013-02-04 |
US20120149591A1 (en) | 2012-06-14 |
AU2003260786A1 (en) | 2004-03-29 |
DK1534830T3 (da) | 2011-02-14 |
US20060035232A1 (en) | 2006-02-16 |
PT1534830E (pt) | 2011-01-31 |
US7842476B2 (en) | 2010-11-30 |
CN100351375C (zh) | 2007-11-28 |
JP2005537795A (ja) | 2005-12-15 |
CA2497496A1 (en) | 2004-03-18 |
CN1681924A (zh) | 2005-10-12 |
NO20051685L (no) | 2005-06-06 |
ATE488586T1 (de) | 2010-12-15 |
IL166903A (en) | 2012-06-28 |
KR101051245B1 (ko) | 2011-07-21 |
WO2004022746A1 (en) | 2004-03-18 |
CA2497496C (en) | 2012-05-15 |
EP2385118A1 (en) | 2011-11-09 |
DE60335000D1 (de) | 2010-12-30 |
JP4664677B2 (ja) | 2011-04-06 |
KR20050057216A (ko) | 2005-06-16 |
EP1534830A1 (en) | 2005-06-01 |
US8679781B2 (en) | 2014-03-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1072957A1 (en) | In vitro peptide expression libraray | |
WO2002046407A3 (en) | Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof | |
WO2002040683A3 (en) | Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof | |
WO2002046406A3 (en) | Human transporter proteins, nucleic acid molecules encoding them,and uses thereof | |
WO2001081412A3 (en) | Isolated human transporter proteins, nucleic acid molecules encoding the same, and uses thereof | |
WO2002022678A3 (en) | Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof | |
WO2002077190A8 (en) | Isolated human ras-like proteins, nucleic acid molecules encoding these human ras-like proteins, and uses thereof | |
WO2002024910A3 (en) | Isolated human transporter proteins, nucleic acid molecules encoding them, and uses thereof | |
WO2002057310A3 (en) | Human transporter proteins, nucleic acid molecules encoding them, and uses thereof | |
WO2003074675A3 (en) | Isolated human ras-like proteins, nucleic acid molecules encoding these human ras-like proteins, and uses thereof | |
WO2002020757A3 (en) | Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof | |
WO2002046217A3 (en) | Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof | |
WO2002033086A3 (en) | Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof | |
WO2002024748A3 (en) | Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof | |
WO2002072831A3 (en) | Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof | |
WO2002081654A3 (en) | Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof | |
WO2003070882A3 (en) | Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and used thereof | |
WO2002053740A3 (en) | Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof | |
WO2002048366A3 (en) | Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof | |
WO2002048365A3 (en) | Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof | |
WO2002048364A3 (en) | Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof | |
WO2001088136A3 (en) | Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof | |
WO2001090360A3 (en) | Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof | |
WO2002079432A3 (en) | Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof | |
WO2002079225A3 (en) | Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PC | Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee) |
Effective date: 20210905 |